Clinical Trial 44879

Houston, TX 77061


Summary:

NAFLD (non-alcoholic fatty liver disease) /Non-alcoholic steatohepatitis (NASH) is the most common liver disease in the United States. The term NAFLD (non-alcoholic fatty liver disease) describes a range of liver disease progression. When fatty liver disease advances to a more severe level of liver injury, it is called nonalcoholic steatohepatitis (NASH) basically scaring of the liver tissue.
Some risk factors for these diseases include:
• Being overweight
• Type 2 Diabetes
• Elevated Lab Results for: blood sugar, or liver enzymes, or HbA1c


Qualified Participants Must:

• Be over the age of 18
• Be diabetic or borderline diabetic
• Not be taking insulin


Qualified Participants May Receive:

  • Compensation for travel & time 
  • Free lab work 
  • Free fibroscan 
  • Posibility to enroll in future NASH studies 


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.